Jacobs Levy Equity Management, Inc Editas Medicine, Inc. Transaction History

Jacobs Levy Equity Management, Inc

$24.7 Billion
Q3 2024

A detailed history of Jacobs Levy Equity Management, Inc transactions in Editas Medicine, Inc. stock. As of the latest transaction made, Jacobs Levy Equity Management, Inc holds 529,834 shares of EDIT stock, worth $1.47 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

529,834

Previous 227,182 133.22%

Holding current value

$1.47 Million

Previous $1.06 Million 70.38%

% of portfolio

0.01%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$3.39 - $5.96 $1.03 Million - $1.8 Million	302,652 Added 133.22%	529,834 $1.81 Million
Q2 2024 Aug 14, 2024	BUY	$4.67 - $7.28 $504,556 - $786,545	108,042 Added 90.68%	227,182 $1.06 Million
Q1 2024 May 15, 2024	SELL	$7.03 - $11.07 $1.16 Million - $1.83 Million	-165,688 Reduced 58.17%	119,140 $884,000
Q4 2023 Feb 14, 2024	BUY	$6.25 - $11.11 $1.26 Million - $2.24 Million	201,732 Added 242.77%	284,828 $2.89 Million
Q3 2023 Nov 16, 2023	BUY	$6.92 - $9.31 $448,014 - $602,748	64,742 Added 352.74%	83,096 $648,000
Q2 2023 Aug 14, 2023	BUY	$6.36 - $11.47 $116,731 - $210,520	18,354 New	18,354 $151,000
Q4 2022 Feb 14, 2023	SELL	$8.32 - $13.21 $765,731 - $1.22 Million	-92,035 Reduced 85.9%	15,103 $133,000
Q3 2022 Nov 15, 2022	BUY	$12.16 - $19.42 $1.3 Million - $2.08 Million	107,138 New	107,138 $1.31 Million
Q2 2022 Aug 15, 2022	SELL	$9.99 - $21.35 $755,833 - $1.62 Million	-75,659 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$14.08 - $27.63 $1.07 Million - $2.09 Million	75,659 New	75,659 $1.44 Million
Q1 2021 May 17, 2021	SELL	$39.71 - $90.58 $2.75 Million - $6.28 Million	-69,345 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$27.07 - $84.35 $559,672 - $1.74 Million	-20,675 Reduced 22.97%	69,345 $4.86 Million
Q3 2020 Nov 16, 2020	SELL	$28.06 - $37.16 $630,620 - $835,133	-22,474 Reduced 19.98%	90,020 $2.53 Million
Q2 2020 Aug 17, 2020	BUY	$18.5 - $34.34 $832,925 - $1.55 Million	45,023 Added 66.73%	112,494 $3.33 Million
Q1 2020 May 15, 2020	BUY	$14.88 - $32.78 $504,342 - $1.11 Million	33,894 Added 100.94%	67,471 $1.34 Million
Q4 2019 Feb 14, 2020	BUY	$19.49 - $32.63 $654,415 - $1.1 Million	33,577 New	33,577 $994,000

Others Institutions Holding EDIT

# of Institutions

245

Shares Held

56.4M

Call Options Held

399K

Put Options Held

394K

View Full List

About Editas Medicine, Inc.

Ticker EDIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,737,200
Market Cap $190M
Description
Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...

More about EDIT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jacobs Levy Equity Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Jacobs Levy Equity Management, Inc with notifications on news.

Account

Jacobs Levy Equity Management, Inc Editas Medicine, Inc. Transaction History